Researcher

Losen, M.R.

Assistant Professor

View graph of relations
  1. 2005
  2. Published
  3. 2006
  4. Published
  5. 2010
  6. Published
    Gomez, A. M., Van den Broeck, J., Vrolix, K., Janssen, S. P., Lemmens, M. A. M., van der Esch, E., ... Losen, M. (2010). Antibody effector mechanisms in myasthenia gravis-Pathogenesis at the neuromuscular junction. Autoimmunity, 43(5-6), 353-370. https://doi.org/10.3109/08916930903555943
  7. Published
  8. Published
  9. Published
  10. Published
  11. Published
  12. 2011
  13. Published
  14. Published
  15. Published
  16. Published
  17. 2012
  18. Published
  19. Published
  20. Published
  21. Published
    Klooster, R., Plomp, J. J., Huijbers, M. G., Niks, E. H., Straasheijm, K. R., Detmers, F. J., ... Verschuuren, J. J. (2012). Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain, 135, 1081-1101. https://doi.org/10.1093/brain/aws025
  22. Published
  23. Published
  24. 2013
  25. Published
  26. Published
  27. Published
  28. 2014
  29. Published
  30. Published
  31. Published
    Zisimopoulou, P., Evangelakou, P., Tzartos, J., Lazaridis, K., Zouvelou, V., Mantegazza, R., ... Tzartos, S. J. (2014). A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis. Journal of Autoimmunity, 52, 139-145. https://doi.org/10.1016/j.jaut.2013.12.004
  32. Published
  33. Published
  34. Published
  35. Published
  36. 2015
  37. Published
  38. Published
  39. Published
    Bode, G. H., Pickl, K. E., Sanchez-Purra, M., Albaiges, B., Borros, S., Poetgens, A. J. G., ... Martinez-Martinez, P. (2015). Detection of Peptide-Based Nanoparticles in Blood Plasma by ELISA. PLOS ONE, 10(5), [e0126136]. https://doi.org/10.1371/journal.pone.0126136
  40. Published
  41. Published
    Tsonis, A. I., Zisimopoulou, P., Lazaridis, K., Tzartos, J., Matsigkou, E., Zouvelou, V., ... Tzartos, S. J. (2015). MuSK autoantibodies in myasthenia gravis detected by cell based assay - A multinational study. Journal of Neuroimmunology, 284, 10-17. https://doi.org/10.1016/j.jneuroim.2015.04.015
  42. Published
    Phillips, W. D., Christadoss, P., Losen, M., Punga, A. R., Shigemoto, K., Verschuuren, J., & Vincent, A. (2015). Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis. Experimental Neurology, 270, 29-40. https://doi.org/10.1016/j.expneurol.2014.12.013
  43. Published
  44. Published
  45. Published
  46. 2016
  47. Published
  48. Published
  49. Published
    Stergiou, C., Lazaridis, K., Zouvelou, V., Tzartos, J., Mantegazza, R., Antozzi, C., ... Tzartos, S. J. (2016). Titin antibodies in "seronegative" myasthenia gravis - A new role for an old antigen. Journal of Neuroimmunology, 292, 108-115. https://doi.org/10.1016/j.jneuroim.2016.01.018
  50. Published
    Kohler, S., Losen, M., Alexander, T., Hiepe, F., & Meisel, A. (2016). Myasthenia gravis: subgroup classifications. Lancet Neurology, 15(4), 356-357. https://doi.org/10.1016/S1474-4422(16)00033-8
  51. Published
  52. Published
  53. 2017
  54. Published
  55. Published
  56. Published
  57. Published
  58. Published
  59. Published
  60. 2018
  61. Published
    Verschuuren, J. J. G. M., Plomp, J. J., Burden, S. J., Zhang, W., Fillie-Grijpma, Y. E., Stienstra-van Es, I. E., ... Huijbers, M. G. (2018). Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies. Annals of the New York Academy of Sciences, 1413(1), 111-118. https://doi.org/10.1111/nyas.13543
Previous 1 2 Next